Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.17% is 81% below its 5-year average of 6.23%, near the low end of its 5-year range (1.17%–17.64%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.04% below its 12-month average of 1.33%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.17%.
DEBT TO ASSETS RATIO
1.17%
DEBT TO ASSETS RATIO AVG TTM
1.33%
DEBT TO ASSETS RATIO AVG 3Y
1.84%
DEBT TO ASSETS RATIO AVG 5Y
6.23%
DEBT TO ASSETS RATIO AVG 10Y
4.99%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-12.04%
CURRENT VS 3Y AVG
-36.34%
CURRENT VS 5Y AVG
-81.21%
CURRENT VS 10Y AVG
-76.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 469 covered companies
CURRENT VS SECTOR MEDIAN
+964.32%
vs the sector median at left
BeyondSpring Inc.
Market Cap
$32.32M
Debt to Assets Ratio
1.17%
TTM Avg
1.33%
3Y Avg
1.84%
5Y Avg
6.23%
Market Cap
$32.31M
Debt to Assets Ratio
1.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.36M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.42M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.52M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.92M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.89M
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | $32.32M | 1.17% | 1.33% | 1.84% | 6.23% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | 1.40% | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 0.19% | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | 0.05% | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 0.00% | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.01% | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $35.89M | 0.41% | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.05M | 0.14% | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | 0.16% | N/A | N/A | N/A |
Debt/Assets
1.2%
Debt/Equity
N/A
Current Ratio
0.70
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.17% |
| 2026-03-31 | 1.34% |
| 2025-12-31 | 1.23% |
| 2025-09-30 | 1.38% |
| 2025-06-30 | 1.54% |
| 2025-03-31 | 1.47% |
| 2024-12-31 | 1.72% |
| 2024-09-30 | 1.72% |
| 2024-06-30 | 17.64% |
| 2024-03-31 | 17.64% |
| 2023-12-31 | 3.41% |
| 2023-09-30 | 3.41% |
| 2023-06-30 | 13.60% |
| 2023-03-31 | 13.60% |
| 2022-12-31 | 10.73% |
| 2022-09-30 | 10.73% |
| 2022-06-30 | 8.28% |
| 2022-03-31 | 8.28% |
| 2021-12-31 | 4.38% |
| 2021-09-30 | 3.62% |
| 2021-06-30 | 3.94% |
| 2021-03-31 | 3.44% |
| 2020-12-31 | 3.69% |
| 2020-09-30 | 11.04% |
| 2020-06-30 | 9.64% |
| 2020-03-31 | 11.91% |
| 2019-12-31 | 8.84% |
| 2019-09-30 | 11.81% |
| 2019-06-30 | 117.84% |
| 2019-03-31 | 82.13% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.01% |
| 2016-12-31 | 1.41% |
| 2016-09-30 | 1.87% |
| 2016-06-30 | 0.00% |
| 2015-12-31 | 0.00% |
